Akebia Therapeutics Inc. (AKBA)
1.90
-0.02 (-1.04%)
At close: Apr 01, 2025, 3:59 PM
1.93
1.37%
Pre-market: Apr 02, 2025, 04:04 AM EDT
Akebia Therapeutics Revenue
Akebia Therapeutics reported an annual revenue of $160.18M, reflecting a -17.7% growth. For the quarter ending December 31, 2024, Akebia Therapeutics generated $46.5M in revenue.
Revenue (ttm)
$160.18M
Revenue Growth
-17.7%
Price / Sales Ratio
2.5
Revenue / Employee
$884.97K
Employees
181
Market Cap
496.34M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 160.18M | -17.70% |
| Dec 31, 2023 | 194.62M | -33.49% |
| Dec 31, 2022 | 292.6M | +37.00% |
| Dec 31, 2021 | 213.58M | -27.68% |
| Dec 31, 2020 | 295.31M | n/a |